OTCMKTS:CDXI

Cardax Stock Forecast, Price & News

$2.10
0.00 (0.00 %)
(As of 04/13/2021 12:00 AM ET)
Add
Compare
Today's Range
$2.10
Now: $2.10
$2.10
50-Day Range
$1.78
MA: $2.15
$3.00
52-Week Range
$1.15
Now: $2.10
$15.00
VolumeN/A
Average Volume488 shs
Market Capitalization$1.67 million
P/E RatioN/A
Dividend YieldN/A
Beta1.35
Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an anti-inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate; and CDX-301, a zeaxanthin pharmaceutical candidate for pharmaceutical applications. The company has a joint development and supply agreement with BASF SE, as well as a collaboration agreement with Capsugel US, LLC for the development of astaxanthin products for the consumer health market. Cardax, Inc. is based in Honolulu, Hawaii.
Cardax logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CDXI
CUSIPN/A
CIKN/A
Phone808 457 1400
Employees11
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$710,000.00
Book Value($10.52) per share

Profitability

Net Income$-5,090,000.00
Net Margins-891.77%

Miscellaneous

Market Cap$1.67 million
Next Earnings Date5/21/2021 (Estimated)
OptionableNot Optionable

Headlines

Cardax (OTCMKTS:CDXI) Stock Price Down 11.1%
April 7, 2021 |  americanbankingnews.com
See More Headlines

MarketRank

Overall MarketRank

0.00 out of 5 stars

Medical Sector

1893rd out of 2,019 stocks

Pharmaceutical Preparations Industry

751st out of 772 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$2.10
0.00 (0.00 %)
(As of 04/13/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CDXI News and Ratings via Email

Sign-up to receive the latest news and ratings for CDXI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cardax (OTCMKTS:CDXI) Frequently Asked Questions

What stocks does MarketBeat like better than Cardax?

Wall Street analysts have given Cardax a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cardax wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Cardax's next earnings date?

Cardax is scheduled to release its next quarterly earnings announcement on Friday, May 21st 2021.
View our earnings forecast for Cardax
.

Who are Cardax's key executives?

Cardax's management team includes the following people:
  • Mr. David G. Watumull, Pres, CEO & Director (Age 71, Pay $198.65k)
  • Mr. David M. Watumull, COO, Sec. & Assistant Treasurer (Age 39, Pay $156.22k)
  • Dr. Gilbert M. Rishton Ph.D., Chief Science Officer
  • Mr. John B. Russell CPA, CPA, CFO & Treasurer (Age 48)
  • Mr. Gilbert Shin, VP of Retail Sales & Marketing
  • Dr. Jon L. Ruckle, Chief Medical Officer

Who are some of Cardax's key competitors?

What is Cardax's stock symbol?

Cardax trades on the OTCMKTS under the ticker symbol "CDXI."

How do I buy shares of Cardax?

Shares of CDXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cardax's stock price today?

One share of CDXI stock can currently be purchased for approximately $2.10.

How much money does Cardax make?

Cardax has a market capitalization of $1.67 million and generates $710,000.00 in revenue each year.

How many employees does Cardax have?

Cardax employs 11 workers across the globe.

What is Cardax's official website?

The official website for Cardax is www.cardaxpharma.com.

Where are Cardax's headquarters?

Cardax is headquartered at 2800 WOODLAWN DRIVE SUITE 129, HONOLULU HI, 96822.

How can I contact Cardax?

Cardax's mailing address is 2800 WOODLAWN DRIVE SUITE 129, HONOLULU HI, 96822. The company can be reached via phone at 808 457 1400 or via email at [email protected]


This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.